Karolinska Development's portfolio company SVF Vaccines appoints Dr Gaston Picchio as acting CEO

Posted 2024-11-15, Nasdaq Globe Newswire Headlines

STOCKHOLM, Sweden, 15 November 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company SVF Vaccines has... read full story

Ask about this article

Answer for your question of the article will be displayed here ...

Related News

Karolinska Development's portfolio company SVF Vaccines appoints Dr Gaston Picchio as acting CEO (Karolinska Development AB)

Public Technologies 2024-11-15, 07:55

Karolinska Development's portfolio company Modus Therapeutics secures bridge financing (Karolinska Development AB)

Public Technologies 2024-11-19, 16:51

Karolinska Development's portfolio company Umecrine Cognition presents positive interim data from Phase 1b/2a clinical study (Karolinska Development AB)

Public Technologies 2024-11-18, 08:54

Related News

Karolinska Development’s portfolio company BOOST Pharma successfully completes pre-IND meeting with FDA and receives second ...

Nasdaq Globe Newswire
2024-11-05, 07:50

Karolinska Development's portfolio company BOOST Pharma successfully completes pre-IND meeting with FDA and receives second tranche of investment (Karolinska Development AB)

Public Technologies
2024-11-05, 07:56

Karolinska Development's portfolio company Modus Therapeutics secures bridge financing

Nasdaq Globe Newswire
2024-11-19, 16:53

Karolinska Development’s portfolio company Umecrine Cognition presents positive interim data from Phase 1b/2a clinical study

Nasdaq Globe Newswire
2024-11-18, 08:33

Karolinska Development’s Extraordinary General Meeting 2024 (Karolinska Development AB)

Public Technologies
2024-11-13, 11:57

Karolinska Development's Extraordinary General Meeting 2024 (Karolinska Development AB)

Public Technologies
2024-11-13, 11:57

Karolinska Development’s Extraordinary General Meeting 2024

Nasdaq Globe Newswire
2024-11-13, 12:09

Truecaller: Additional information following the announcement of appointment of a new CEO

PR Newswire
2024-11-06, 19:29